You can in some cases live longer with immunotherapy although the length of time that you live longer on immunotherapy will depend on your age, overall health and how far progressed the cancer is.
Some people that have cancer and are on immunotherapy can live longer by way of harnessing the power of your immune system to fight off cancer cells and studies have also shown improvement in survival rates in various cancers when on immunotherapy.
Immunotherapy works by training the body's immune system to recognize and attack the cancer cells.
Studies have also shown that immunotherapy can also lead to longer event free survival and overall survival when compared to traditional treatments such as chemotherapy alone.
Some examples of success in use of immunotherapy for cancer include.
Non small cell lung cancer, studies such as KEYNOTE-024 and KEYNOTE-042 have demonstrated improved survival rates with immunotherapy.
And in metastatic melanoma, the combination of nivolumab and ipilimumab has also shown long term benefits and Atezolizumab, which is a PDL-inhibitor, has also shown improved survival in state IV NSCLC.
Immunotherapy while can be successful in some people, it does not work for everyone, and the effectiveness of immunotherapy can vary depending on the type of the cancer, state as well as individual patient factors.
And people with KRAS mutation and high levels of PDL-1 often live longer when treated with immunotherapy alone.
Immunotherapy is a cancer treatment which uses your body's own immune system to fight the cancer and can also be used to treat autoimmune diseases.
Immunotherapy also boosts your immune system to find and attack cancer cells and targets specific antigens on cancer cells and it trains your immune system to attack specific cancer cells.